Multivalent Methionine‐functionalized Biocompatible Block Copolymers for Targeted Small Interfering RNA Delivery and Subsequent Reversal Effect on Adriamycin Resistance in Human Breast Cancer Cell Line MCF‐7/ADR

Yang Wu,Wei Zhang,Tinghan Li,Rong Ma,Dan Chen,Junying Zhang,Jianzhong Wu,Jinhai Tang
DOI: https://doi.org/10.1002/jgm.2969
2017-01-01
Abstract:BACKGROUND:Cationic polymers are outstanding representatives of the most efficient small interfering RNA (siRNA) vectors. Low cytotoxicity and siRNA protecting effect can be obtained with these cationic polymers via a variety of structural modifications. Nevertheless, the gap between their efficiency and the requirement for therapeutic processes is still noticeable.METHODS:A cationic polymer vector was synthesized via the copolymerization of N-(1,3-dihydroxy propan-2-yl)methacrylamide (DHPMA) and N-(3-aminopropyl)methacrylamide (APMA).RESULTS:APMA provides amine functionality that allows the conjugation of guanidine and methionine groups. Attributed to the hydroxy groups of DHPMA, the synthesized guanidine and methionine grafted DHPMA-b-APMA block copolymer (mDG) is water soluble and has good biocompatibility. The obtained mDG has high zeta potential, narrow molecular weight distribution, better membrane-penetrating ability, high transfection efficiency, tumor cell targeting ability and high stability.CONCLUSIONS:The synthesized polymer vector can deliver siRNA molecules into tumor cells and then reverse drug resistance by down regulation of P-glycoprotein mRNA expression.
What problem does this paper attempt to address?